Lersivirine
Lersivirine (UK-453061) is a next-generation NNRTI developed for the treatment of HIV-1 infection. It has demonstrated potent antiviral activity in vitro and has been evaluated in clinical trials for its efficacy against both wild-type and drug-resistant virus strains.
Product Specifications
CAS Number
473921-12-9
Product Name Alternative
NNRTI, NNRTI-resistant, inhibit, Inhibitor, non-nucleoside reverse transcription, Lersivirine, Lersivirine (UK 453061), HIV, HIVProtease, HIV virus, HIV Protease, Human immunodeficiency virus, resistant strain, ReverseTranscriptase, Reverse Transcriptase, UK 453061, UK453061, UK-453061
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Purity
98.01% (May vary between batches)
Solubility
DMSO:50 mg/mL (161.11 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (8.06 mM)
Smiles
CCc1nn (CCO) c (CC) c1Oc1cc (cc (c1) C#N) C#N
Molecular Formula
C17H18N4O2
Molecular Weight
310.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS022008-01 48 Well
Mouse Acidic Fibroblast Growth Factor ELISA Kit
Sign In for Pricing
View Details MBS022008-02 96 Well
Mouse Acidic Fibroblast Growth Factor ELISA Kit
Sign In for Pricing
View Details MBS022008-03 5x 96 Well
Mouse Acidic Fibroblast Growth Factor ELISA Kit
Sign In for Pricing
View Details MBS022008-04 10x 96 Well
Mouse Acidic Fibroblast Growth Factor ELISA Kit
Sign In for Pricing
View Details